Marksans Pharma consolidated net profit rises 31.27% in the December 2023 quarter
Sales rise 22.15% to Rs 586.13 crore
Net profit of Marksans Pharma rose 31.27% to Rs 83.24 crore in the quarter ended December 2023 as against Rs 63.41 crore during the previous quarter ended December 2022. Sales rose 22.15% to Rs 586.13 crore in the quarter ended December 2023 as against Rs 479.83 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales586.13479.83 22 OPM %22.6915.97 -PBDT134.6691.94 46 PBT112.6679.20 42 NP83.2463.41 31Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 13 2024 | 4:31 PM IST